Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT05654883

New York City Observational Study of Mpox Immunity

Sponsor: NYU Langone Health

View on ClinicalTrials.gov

Summary

The goal of this study is to assess the immune response, tolerance, and safety of the low-dose intradermal (forearm) mpox vaccine in people who are HIV+ compared to people who are HIV-, and compared to the standard-dose subcutaneous (upper arm) vaccine. The resulting data will fill knowledge gaps, inform public health practices, and address community concerns about the absence of data for low-dose intradermal mpox vaccinations in people living with HIV.

Official title: New York City Observational Study of Mpox Immunity: NYC OSMI

Key Details

Gender

All

Age Range

18 Years - 100 Years

Study Type

OBSERVATIONAL

Enrollment

174

Start Date

2022-11-11

Completion Date

2026-06

Last Updated

2025-10-30

Healthy Volunteers

Yes

Locations (1)

NYU Langone Health

New York, New York, United States